diff --git a/apps/docs/scripts/auth-cli.ts b/apps/docs/scripts/auth-cli.ts index ae6eca1..76f67f5 100644 --- a/apps/docs/scripts/auth-cli.ts +++ b/apps/docs/scripts/auth-cli.ts @@ -184,8 +184,8 @@ async function main() { const research = await researchResponse.json(); assert.equal(research.companies.length, 1051); assert.equal(research.categories.length, 11); - assert.equal(research.evidence.length, 1958); - assert.equal(research.observations.length, 251); + assert.equal(research.evidence.length, 1991); + assert.equal(research.observations.length, 258); assert.equal((await request("/api/research/ai-companies", { method: "POST", headers })).status, 405); const researchPage = await request("/docs/other-research/ai-company-research/overview", { headers }); assert.equal(researchPage.status, 200); diff --git a/apps/docs/tests/research.test.ts b/apps/docs/tests/research.test.ts index 7fe6eff..2d36d2c 100644 --- a/apps/docs/tests/research.test.ts +++ b/apps/docs/tests/research.test.ts @@ -24,8 +24,8 @@ test("research revisions share the authentication database and preserve replay l assert.equal(consumeCode(config, "invalid"), "limited"); const initial = readResearchSnapshot(); assert.equal(initial.companies.length, 1051); - assert.equal(initial.evidence.length, 1958); - assert.equal(initial.observations.length, 251); + assert.equal(initial.evidence.length, 1991); + assert.equal(initial.observations.length, 258); assert.deepEqual(initial.candidateBatches, seed.candidateBatches, "candidate gaps persist in the same database metadata"); assert.deepEqual(initial.directoryRechecks, seed.directoryRechecks, "follow-up classifications persist without rewriting the discovery audit"); assert.deepEqual(readResearchSnapshot(), initial, "reopening does not duplicate records"); @@ -64,7 +64,7 @@ test("research validation rejects broken evidence and unsafe source links", () = test("reviews link explicit companies without turning global or excluded cases into companies", () => { const snapshot = structuredClone(seed) as ResearchSnapshot; - assert.equal(snapshot.reviews.filter((r) => r.scope === "companies").length, 120); + assert.equal(snapshot.reviews.filter((r) => r.scope === "companies").length, 121); assert.equal(snapshot.reviews.filter((r) => r.scope === "dataset").length, 12); assert.equal(snapshot.reviews.filter((r) => r.scope === "excluded-candidate").length, 44); const review = snapshot.reviews.find((r) => r.id === "R4")!; diff --git a/content/research/ai-companies.seed.json b/content/research/ai-companies.seed.json index a6177e0..faad5ae 100644 --- a/content/research/ai-companies.seed.json +++ b/content/research/ai-companies.seed.json @@ -1,5 +1,5 @@ { - "version": "2026-10-31-industry-3", + "version": "2026-10-31-industry-4", "asOf": "2026-10-31", "scope": "全球公开资料研究：保留首批个案，并扩展核查2025—2026八个YC批次候选池；成立年份以官方公司页面字段为依据。", "limitations": [ @@ -12281,31 +12281,33 @@ "id": "YC30962", "name": "Denki", "url": "https://www.ycombinator.com/companies/denki", - "cat": "C07", + "cat": "C05", "year": 2025, "team": 4, "location": "San Francisco", - "business": "公司简介：The full-stack AI financial audit firm", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "自动处理企业内审计划、证据收集、控制测试及底稿。", + "buyer": "跨行业企业SOX及内部审计团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "移企业通用工作；99%软件/1%服务是自述，未核收入及交付人力构成。法规及审计追溯不等已核审计有效性，不把行业2900亿支出当营收。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-30962" + "YC-E-30962", + "INDUSTRY4-CAT-YC30962" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：自动处理企业内审计划、证据收集、控制测试及底稿。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "FinOps", "Compliance", "AI", "AI Assistant" - ] + ], + "businessModel": "通用内审软件加服务；控制、流程、许可与实施费待拆" }, { "id": "YC30963", @@ -12426,22 +12428,25 @@ "year": 2025, "team": 3, "location": "San Francisco", - "business": "公司简介：Exonic is an AI-native cell and gene therapeutics company.", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "研发具有情境响应特性的遗传治疗技术。", + "buyer": "遗传治疗研发团队及药企，买家待核", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留生物医药研发，官网仅称AI适应性医学，AI具体机制与产品交付仍缺。未核临床阶段、疗效、授权或收入，不把研究目标当批准疗法。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-30970" + "YC-E-30970", + "INDUSTRY4-CAT-YC30970", + "INDUSTRY4-EXONIC-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：研发具有情境响应特性的遗传治疗技术。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "专业医药研发；项目、许可、试验及专业人员成本待核" }, { "id": "YC30972", @@ -12476,28 +12481,30 @@ "year": 2025, "team": 3, "location": "New York City, NY", - "business": "公司简介：AI healthcare concierge for employees", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为雇主员工提供短信入口、虚拟诊所及就医导航协调。", + "buyer": "雇主健康计划及员工", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留医疗服务，包含真实临床交付不全作软件。10至20%节省为自述，前Cedar数百万ARR及百万用户不归Rovi，临床结果、牌照和费用未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-30977" + "YC-E-30977", + "INDUSTRY4-CAT-YC30977" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为雇主员工提供短信入口、虚拟诊所及就医导航协调。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Consumer Health Services", "Health Tech", "Digital Health", "Healthcare", "Health Insurance" - ] + ], + "businessModel": "医疗服务加导航软件；合同、临床人员和按节省收费待拆" }, { "id": "YC30981", @@ -12705,26 +12712,28 @@ "year": 2025, "team": 5, "location": "New York City, NY", - "business": "公司简介：AI-powered market due diligence for investment decisions", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为私募投资决策访谈专家并生成可追溯的市场尽调报告。", + "buyer": "私募股权投资及交易尽调团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留投资研究；8基金合计2.4万亿AUM为客户资产，同行50万至百万报告费不当本公司定价或收入。自动可审计是自述，未核专家样本与报告准确率。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-30993" + "YC-E-30993", + "INDUSTRY4-CAT-YC30993" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为私募投资决策访谈专家并生成可追溯的市场尽调报告。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Analytics", "Market Research", "AI" - ] + ], + "businessModel": "专业研究服务加AI；项目、访谈、数据和人力费用待拆" }, { "id": "YC30995", @@ -12831,22 +12840,25 @@ "year": 2026, "team": 9, "location": "San Francisco", - "business": "公司简介：A premier AI-native law firm & legal operating system for Startups.", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "由律师及助理配合软件提供创业公司法律服务。", + "buyer": "科技创业公司及投资者", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留法律服务；官网区分Vector Legal PC法律服务与Vector Systems PBC平台，不能把两者收入直接合并。十三年经验、六成降价及执照均未独立核，AI草稿需律师审。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31000" + "YC-E-31000", + "INDUSTRY4-CAT-YC31000", + "INDUSTRY4-VECTOR-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：由律师及助理配合软件提供创业公司法律服务。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "律师事务所服务加软件；时费、成果费、月顾问及专业工时待拆" }, { "id": "YC31001", @@ -12886,27 +12898,29 @@ "year": 2025, "team": 8, "location": "San Francisco", - "business": "公司简介：AI agents for your healthcare back-office operations.", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为医疗机构及RCM团队自动执行账单及后台操作。", + "buyer": "医疗收入运营公司及医疗机构", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留医疗行业，旧招聘和高管搜索后台发布分期。SOC2/HIPAA为自述，未取得独立报告；旧客户及行业成果不自动归当前产品。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31002" + "YC-E-31002", + "INDUSTRY4-CAT-YC31002" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为医疗机构及RCM团队自动执行账单及后台操作。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Health Tech", "Healthcare", "Health Insurance", "AI" - ] + ], + "businessModel": "医疗后台自动化；任务、实施、系统及人工升级费用待拆" }, { "id": "YC31005", @@ -12916,27 +12930,29 @@ "year": 2025, "team": 4, "location": "Atlanta, GA", - "business": "公司简介：Compliance that makes products ready for global markets.", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为食品及化妆品品牌分析配方、包装和新市场合规材料。", + "buyer": "消费品牌跨境及法规团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留产品监管专业应用；当前初始美国市场与旧泛贸易合规分期。market-ready标签是交付主张，不当监管批准或法律意见，准确性未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31005" + "YC-E-31005", + "INDUSTRY4-CAT-YC31005" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为食品及化妆品品牌分析配方、包装和新市场合规材料。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Workflow Automation", "Compliance", "Consumer Products", "AI" - ] + ], + "businessModel": "产品合规软件加专业服务；产品、市场、文件和审核费待拆" }, { "id": "YC31007", @@ -13034,26 +13050,28 @@ "year": 2025, "team": 2, "location": "San Francisco", - "business": "公司简介：AI plug-in that automates HR immigration screening and compliance", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为国际招聘流程整理签证材料、资格线索和律师表格。", + "buyer": "企业国际招聘及移民法律团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留移民专业应用，HR入口不是通用HR全流程。eligibility检查未独立核，不当政府批准、法律服务资格或保证只出现合规候选。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31020" + "YC-E-31020", + "INDUSTRY4-CAT-YC31020" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为国际招聘流程整理签证材料、资格线索和律师表格。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "GovTech", "LegalTech", "Immigration" - ] + ], + "businessModel": "移民合规软件；申请、连接、文档及律师审核费待拆" }, { "id": "YC31022", @@ -13122,27 +13140,29 @@ "year": 2025, "team": 1, "location": "Seattle, WA", - "business": "公司简介：AI automated prior-auths for private medical practices", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为私人诊所处理医疗事先授权。", + "buyer": "私人医疗机构及授权团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "简介短暂留医疗专业工作，端到端、更便宜更准为自述。未核支付方接受、授权成功率、实际人工和收费。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31025" + "YC-E-31025", + "INDUSTRY4-CAT-YC31025" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为私人诊所处理医疗事先授权。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Digital Health", "Healthcare", "AI", "AI Assistant" - ] + ], + "businessModel": "医疗授权软件或服务；申请、连接和人工成本待核" }, { "id": "YC31030", @@ -13152,27 +13172,30 @@ "year": 2025, "team": 4, "location": "San Francisco", - "business": "公司简介：Operational Intelligence for Global Logistics", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "结合仓储、运输及ERP数据优化物流计划并执行工作流。", + "buyer": "物流、分销及制造运营团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留物流行业，官网Nomos优化与Talon执行分工清楚。operational superintelligence是宣传，不归基础模型；写回和例外升级未运行核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31030" + "YC-E-31030", + "INDUSTRY4-CAT-YC31030", + "INDUSTRY4-HALADIR-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：结合仓储、运输及ERP数据优化物流计划并执行工作流。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Logistics", "Supply Chain", "Operations", "AI" - ] + ], + "businessModel": "物流规划执行软件；优化、流程、系统和部署成本待拆" }, { "id": "YC31036", @@ -13234,26 +13257,28 @@ "id": "YC31048", "name": "FullSeam", "url": "https://www.ycombinator.com/companies/fullseam", - "cat": "C07", + "cat": "C05", "year": 2026, "team": 3, "location": null, - "business": "公司简介：AI agents for corporate accounting teams", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为企业处理应付、应收及对账等会计工作。", + "buyer": "跨行业企业内部财务团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "移企业通用财务；前TaxProper每年十亿客户税款及被收购经历不归FullSeam收入或退出。自动处理和系统外任务比例未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31048" + "YC-E-31048", + "INDUSTRY4-CAT-YC31048" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为企业处理应付、应收及对账等会计工作。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "通用会计自动化；单据、任务、实施和服务费用待拆" }, { "id": "YC31051", @@ -13296,22 +13321,24 @@ "year": 2025, "team": 3, "location": "San Francisco", - "business": "公司简介：Insurance risk layer for physical AI", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为保险公司模拟自动驾驶及机器人任务的损失风险。", + "buyer": "保险定价及风险模型团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留保险专业分析，不据foundational layer归基础模型。模拟损失不是实际索赔或保险收入，前公司50亿并购及FAA认证旧项目不归Valgo资质。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31057" + "YC-E-31057", + "INDUSTRY4-CAT-YC31057" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为保险公司模拟自动驾驶及机器人任务的损失风险。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "专业风险分析模型软件；模型、数据、项目及专家成本待拆" }, { "id": "YC31063", @@ -13342,30 +13369,33 @@ "id": "YC31064", "name": "Origin", "url": "https://www.ycombinator.com/companies/origin-bio", - "cat": "C07", + "cat": "C02", "year": 2025, "team": 8, "location": "San Francisco", - "business": "公司简介：AI and Data for Cancer Therapeutics", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "生产并许可患者来源肿瘤数据，用于药企分析及AI模型研究。", + "buyer": "药企及AI生物模型研发团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "按当前数据供给移C02，兼医药科研客户；旧疗法研发定位分期。自营实验室、患者许可和模型效果未独立核，官网药品营收表不是Origin收入。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31064" + "YC-E-31064", + "INDUSTRY4-CAT-YC31064", + "INDUSTRY4-ORIGIN-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：生产并许可患者来源肿瘤数据，用于药企分析及AI模型研究。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "AI-powered Drug Discovery", "Biotech", "AI" - ] + ], + "businessModel": "模型及科研数据供给；数据许可、实验室、样本和专业审核成本待拆" }, { "id": "YC31066", @@ -13430,22 +13460,24 @@ "year": 2025, "team": 3, "location": "San Francisco", - "business": "公司简介：AI Native Commercial Insurance Brokerage", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "由经纪人员及AI内部流程为企业配置复杂保险。", + "buyer": "商业保险客户及特殊风险企业", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留保险行业，不把AI-native当纯SaaS。牌照与实际合同未核，1250亿E&S保费为行业规模，不能乘假设份额估平台ARR。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31077" + "YC-E-31077", + "INDUSTRY4-CAT-YC31077" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：由经纪人员及AI内部流程为企业配置复杂保险。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "保险经纪服务；佣金、服务、保费转付及人工待拆" }, { "id": "YC31082", @@ -13486,27 +13518,29 @@ "year": 2025, "team": 3, "location": "San Francisco", - "business": "公司简介：Underwrite borrowers around the world in minutes", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为新兴市场贷款机构整理申请、核验财务材料并提供风险信号。", + "buyer": "贷款机构信贷及风控团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留金融信贷应用；偿还反馈学习与更好决策是自述，未核实际效果或公平性。贷款金额、客户回款和旧雇主用户不作供应商收入。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31083" + "YC-E-31083", + "INDUSTRY4-CAT-YC31083" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为新兴市场贷款机构整理申请、核验财务材料并提供风险信号。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Fintech", "Computer Vision", "Lending", "Emerging Markets" - ] + ], + "businessModel": "贷款运营软件；申请、验证、数据和部署费用待拆" }, { "id": "YC31086", @@ -13516,26 +13550,29 @@ "year": 2026, "team": 5, "location": "San Francisco", - "business": "公司简介：Superintelligent health insurance that keeps employees healthy", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为雇主组织健康福利、保险方案及运营服务。", + "buyer": "雇主健康计划及员工福利团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留医疗保险服务；仅省钱时收费为发布自述，具体合同未核。官网87.5万节省、零免赔及员工报价示例不当收入、普遍价格或独立医疗效果，payer/provider愿景分期。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31086" + "YC-E-31086", + "INDUSTRY4-CAT-YC31086", + "INDUSTRY4-PRESCIENCE-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为雇主组织健康福利、保险方案及运营服务。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "B2B", "Health Insurance", "Insurance" - ] + ], + "businessModel": "健康计划和保险服务；保费、行政、按节省收费及医疗成本待拆" }, { "id": "YC31087", @@ -13627,22 +13664,24 @@ "year": 2026, "team": 3, "location": "San Francisco", - "business": "公司简介：AI-Native Med-Legal Firm", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为工伤评估和医法团队整理医疗记录、时间线及报告。", + "buyer": "医法评估、理赔及法律团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留医法行业；合规摘要和更快和解为主张，未核法律/医疗资质。同行40%案件收入及医生增收不归Docura收入，软件和专业服务范围待核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31090" + "YC-E-31090", + "INDUSTRY4-CAT-YC31090" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为工伤评估和医法团队整理医疗记录、时间线及报告。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "专业记录软件与医法服务；案件、页数、报告及人审成本待拆" }, { "id": "YC31098", @@ -13834,22 +13873,25 @@ "year": 2025, "team": 5, "location": "New York City, NY", - "business": "公司简介：The agentic drug company. We simulate human biology.", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "以生物模型和计算平台辅助药物筛选、安全及临床转化。", + "buyer": "药企及药物研发团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留药物研发应用，AI-agent drug company与现平台分期。Cell2Sentence论文及DeepMind合作是底层架构线索，未核公司当前成果或临床疗效；三验证命中不等获批药物。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31113" + "YC-E-31113", + "INDUSTRY4-CAT-YC31113", + "INDUSTRY4-CELLTYPE-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：以生物模型和计算平台辅助药物筛选、安全及临床转化。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "药物研发软件及研究合作；模型、实验、部署与许可费用待拆" }, { "id": "YC31114", @@ -13970,22 +14012,24 @@ "year": 2026, "team": 2, "location": "New York City, NY", - "business": "公司简介：AI EMR for medspas & wellness clinics", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为医疗美容及健康诊所提供病历、前台、支付和营销管理。", + "buyer": "医疗美容及健康诊所", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留诊所全流程，预约获客为模块而非全部业务。前PJT300亿并购及Rilla经历不归Tepali收入或交易规模，医疗合规和实测效果未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31127" + "YC-E-31127", + "INDUSTRY4-CAT-YC31127" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为医疗美容及健康诊所提供病历、前台、支付和营销管理。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "诊所运营软件；地点、许可、支付、模型和实施成本待拆" }, { "id": "YC31128", @@ -14022,22 +14066,24 @@ "year": 2025, "team": 2, "location": "San Francisco", - "business": "公司简介：AI Verification for Insurance", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "以卫星影像及天气资料辅助保险资产核验和理赔。", + "buyer": "农业等保险机构及理赔团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留保险专业工作；11%美国农田为覆盖自述，不当付费客户或收入。监管上月更新是历史发布用语，本轮未核原文，不沿访问日解释成现行许可或即时赔付已实现。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31129" + "YC-E-31129", + "INDUSTRY4-CAT-YC31129" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：以卫星影像及天气资料辅助保险资产核验和理赔。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "保险核验软件；地块、数据、案件和专业审核费待拆" }, { "id": "YC31130", @@ -14096,29 +14142,31 @@ "id": "YC31132", "name": "MouseCat", "url": "https://www.ycombinator.com/companies/mousecat", - "cat": "C07", + "cat": "C05", "year": 2026, "team": 6, "location": "New York City, NY", - "business": "公司简介：AI to fight financial crime", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为企业监测可疑活动并自动调查欺诈及合规风险。", + "buyer": "跨行业企业风险及合规团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "移跨行业企业风控，未仅服务银行。Fortune500与实时模型是自述，不把降低损失当平台收入或已证控制有效，人工决策边界未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2026年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31132" + "YC-E-31132", + "INDUSTRY4-CAT-YC31132" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为企业监测可疑活动并自动调查欺诈及合规风险。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", "directoryTags": [ "Compliance", "Fraud Detection" - ] + ], + "businessModel": "通用企业风险软件；事件、案件、数据和部署费待拆" }, { "id": "YC31133", @@ -14339,22 +14387,25 @@ "year": 2025, "team": 10, "location": "Oslo, Norway", - "business": "公司简介：Global AI-native law firm handling legal work with same-day turnaround", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "由律师配合AI为企业交付合同及其他复杂法律事项。", + "buyer": "企业法务及运营团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留法律服务，律师审核是必要交付。经手30亿交易不是律师费或Moritz收入；旧750客户引语、现250至2500报价和实际收款分开，900万融资排除。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", - "price": "本轮未逐一核验", + "price": "官网原文250至2500/事项，商业合同750起、批量250起；预先固定价。实际合同、币种、律师工时和回款待核", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31146" + "YC-E-31146", + "INDUSTRY4-CAT-YC31146", + "INDUSTRY4-MORITZ-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：由律师配合AI为企业交付合同及其他复杂法律事项。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "律师事务所服务；按文档/事项固定费，专业工时及软件成本待拆" }, { "id": "YC31147", @@ -14420,47 +14471,52 @@ "year": 2025, "team": 4, "location": "San Francisco", - "business": "公司简介：The AI-native Recruiting OS", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为创业公司承接人才搜索、外联、筛选及招聘协调。", + "buyer": "创业公司招聘团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留招聘服务，OS是包装不代表只卖软件。旧发布仅填补职位收费，官网现强调代理交付，具体合同待核；20倍效率和候选保留率未独立测试。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31153" + "YC-E-31153", + "INDUSTRY4-CAT-YC31153", + "INDUSTRY4-PERFECTLY-HOME" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为创业公司承接人才搜索、外联、筛选及招聘协调。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "专业招聘代理加AI；按成功收费自述，搜索、人力和系统成本待拆" }, { "id": "YC31156", "name": "Ventura", "url": "https://www.ycombinator.com/companies/ventura", - "cat": "C07", + "cat": "C06", "year": 2025, "team": 2, "location": "San Francisco", - "business": "公司简介：AI Workforce for Distributors and Manufacturers", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为工业分销及制造销售团队处理报价、订单并衔接ERP。", + "buyer": "工业分销内勤销售及制造销售团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "移客户收入运营；前Develop Health700万ARR和5人团队不归Ventura，前20亿分销客户也非本公司收入或资产。学习SOP能力与当前付费未独立核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31156" + "YC-E-31156", + "INDUSTRY4-CAT-YC31156" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为工业分销及制造销售团队处理报价、订单并衔接ERP。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "销售订单自动化；任务、系统、实施和服务费待拆" }, { "id": "YC31157", @@ -14548,22 +14604,24 @@ "year": 2025, "team": 3, "location": "San Francisco", - "business": "公司简介：Helping Healthcare Providers Speak Any Language", - "buyer": "本轮未逐一核验", - "delivery": "公开YC公司资料；交付与付费使用待核验", - "notes": "目录基础资料；AI相关描述与业务分类均待进一步人工复核。收入、定价和技术能力未逐一核验。", + "business": "为医疗机构提供临床沟通中的实时语言翻译辅助。", + "buyer": "医疗机构及临床沟通团队", + "delivery": "已读YC当前主营及相关发布节选；选定官网另列，实际合同、收入与能力待核。", + "notes": "保留医疗专业语言服务；最安全最准及百万节省均为主张，不当独立测试或合规保证。医院原口译预算不是Opalite收入，适用临床情境与人工替代率未核。 原成立和团队快照保留；主营复核不等财务或技术审计。", "cohort": "2025年成立", "teamBasis": "YC官方页面Team Size；2026-10-30访问快照，业务截至日未注明", "price": "本轮未逐一核验", "stage": "目录公开，商业成熟度待核验", "sourceType": "YC官方页面中的公司自述", "evidenceIds": [ - "YC-E-31163" + "YC-E-31163", + "INDUSTRY4-CAT-YC31163" ], "revenueStatus": "unknown", "profileOnly": true, - "classificationBasis": "主营简介的规则初分", - "directoryTags": [] + "classificationBasis": "2026-10-31人工复核YC当前主营及相关发布节选：为医疗机构提供临床沟通中的实时语言翻译辅助。 按当前买家及交付分类，专业人员、软件、模型数据及保险款项分开。", + "directoryTags": [], + "businessModel": "医疗口译软件；会话、分钟、系统及专业复核费待拆" }, { "id": "YC31164", @@ -34917,6 +34975,111 @@ "evidence": "INDUSTRY3-CAT-YC30735", "selection": "excluded", "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-DILIGENCE-AUM", + "company": "YC30993", + "name": "DiligenceSquared", + "kind": "客户资产或旧经历金额边界", + "value": 2400000000000, + "unit": "原文$，币种待核", + "bound": ">", + "scope": "8家客户基金合计AUM，非DiligenceSquared资产或收入", + "timing": "当前简介，资产截至日未给", + "reason": "客户管理资产不等研究收费，不能按假设费率估ARR", + "evidence": "INDUSTRY4-CAT-YC30993", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-FULLSEAM-OLD-TAX", + "company": "YC31048", + "name": "FullSeam", + "kind": "客户资产或旧经历金额边界", + "value": 1000000000, + "unit": "原文$，币种待核", + "bound": ">", + "scope": "前TaxProper为客户缴付年度税款，非FullSeam收入", + "timing": "2026-02-17发布中的旧业务经历，税款年度未给", + "reason": "客户税款、旧公司收购和平台收费分开，不归当前ARR", + "evidence": "INDUSTRY4-CAT-YC31048", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-VALGO-OLD-MA", + "company": "YC31057", + "name": "Valgo", + "kind": "客户资产或旧经历金额边界", + "value": 5000000000, + "unit": "原文$，币种待核", + "bound": ">", + "scope": "创始人前雇主并购交易额，非Valgo收入", + "timing": "2026-03-06发布及当前简介中的此前经历", + "reason": "前公司交易和角色不归当前公司规模或收入", + "evidence": "INDUSTRY4-CAT-YC31057", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-MORITZ-DEALS", + "company": "YC31146", + "name": "Moritz", + "kind": "客户资产或旧经历金额边界", + "value": 3000000000, + "unit": "原文$，币种待核", + "bound": "=", + "scope": "律师团队经手交易值，非律师费或Moritz收入", + "timing": "当前简介，交易区间及历史/当前范围未给", + "reason": "底层交易额不是法律服务费，主体/团队及期间待核，不推ARR", + "evidence": "INDUSTRY4-CAT-YC31146", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-VENTURA-OLD-ARR", + "company": "YC31156", + "name": "Ventura", + "kind": "客户资产或旧经历金额边界", + "value": 7000000, + "unit": "原文$，币种待核", + "bound": "=", + "scope": "创始人前Develop Health ARR，非Ventura收入", + "timing": "2026-03-15发布称前业务14个月，财务截至日未给", + "reason": "前公司ARR与5人团队不转移给当前公司", + "evidence": "INDUSTRY4-CAT-YC31156", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-TEPALI-OLD-MA", + "company": "YC31127", + "name": "Tepali", + "kind": "客户资产或旧经历金额边界", + "value": 30000000000, + "unit": "原文$，币种待核", + "bound": "=", + "scope": "创始人在PJT经手并购额，非Tepali收入", + "timing": "2026-03-02发布中的旧经历，交易期间未给", + "reason": "投行交易值不作当前诊所软件营收", + "evidence": "INDUSTRY4-CAT-YC31127", + "selection": "excluded", + "comparisonGroup": null + }, + { + "id": "INDUSTRY4-O-PRESCIENCE-SAVING", + "company": "YC31086", + "name": "Prescience, Inc.", + "kind": "客户资产或旧经历金额边界", + "value": 875000, + "unit": "原文$，币种待核", + "bound": "=", + "scope": "官网客户健康方案节省，非Prescience收入", + "timing": "官网当前展示，实际会计期间未给", + "reason": "客户节省及示例报价不等供应商收入，不乘假设分成推ARR", + "evidence": "INDUSTRY4-PRESCIENCE-HOME", + "selection": "excluded", + "comparisonGroup": null } ], "evidence": [ @@ -56457,6 +56620,369 @@ "kind": "公司公开资料复核", "summary": "官网提供采集套件、运输、处理和存储运营，按客户研究需求报价。", "limitation": "AI实际作用未充分核；24小时报价不等签约或履约，样本许可、临床资质、收入与专业成本未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC30962", + "companyId": "YC30962", + "title": "Denki专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/denki", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "自动处理企业内审计划、证据收集、控制测试及底稿。 移企业通用工作；99%软件/1%服务是自述，未核收入及交付人力构成。法规及审计追溯不等已核审计有效性，不把行业2900亿支出当营收。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC30970", + "companyId": "YC30970", + "title": "Exonic专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/exonic", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "研发具有情境响应特性的遗传治疗技术。 保留生物医药研发，官网仅称AI适应性医学，AI具体机制与产品交付仍缺。未核临床阶段、疗效、授权或收入，不把研究目标当批准疗法。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC30977", + "companyId": "YC30977", + "title": "Rovi Health专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/rovi-health", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为雇主员工提供短信入口、虚拟诊所及就医导航协调。 保留医疗服务，包含真实临床交付不全作软件。10至20%节省为自述，前Cedar数百万ARR及百万用户不归Rovi，临床结果、牌照和费用未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC30993", + "companyId": "YC30993", + "title": "DiligenceSquared专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/diligencesquared-inc", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为私募投资决策访谈专家并生成可追溯的市场尽调报告。 保留投资研究；8基金合计2.4万亿AUM为客户资产，同行50万至百万报告费不当本公司定价或收入。自动可审计是自述，未核专家样本与报告准确率。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31000", + "companyId": "YC31000", + "title": "Vector Legal专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/vector-legal", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "由律师及助理配合软件提供创业公司法律服务。 保留法律服务；官网区分Vector Legal PC法律服务与Vector Systems PBC平台，不能把两者收入直接合并。十三年经验、六成降价及执照均未独立核，AI草稿需律师审。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31002", + "companyId": "YC31002", + "title": "Clicks Health专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/clicks-health", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为医疗机构及RCM团队自动执行账单及后台操作。 保留医疗行业，旧招聘和高管搜索后台发布分期。SOC2/HIPAA为自述，未取得独立报告；旧客户及行业成果不自动归当前产品。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31005", + "companyId": "YC31005", + "title": "MarkIt专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/markit", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为食品及化妆品品牌分析配方、包装和新市场合规材料。 保留产品监管专业应用；当前初始美国市场与旧泛贸易合规分期。market-ready标签是交付主张，不当监管批准或法律意见，准确性未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31020", + "companyId": "YC31020", + "title": "Mayflower专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/mayflower", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为国际招聘流程整理签证材料、资格线索和律师表格。 保留移民专业应用，HR入口不是通用HR全流程。eligibility检查未独立核，不当政府批准、法律服务资格或保证只出现合规候选。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31025", + "companyId": "YC31025", + "title": "ClaimGlide专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/claimglide", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为私人诊所处理医疗事先授权。 简介短暂留医疗专业工作，端到端、更便宜更准为自述。未核支付方接受、授权成功率、实际人工和收费。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31030", + "companyId": "YC31030", + "title": "Haladir专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/haladir", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "结合仓储、运输及ERP数据优化物流计划并执行工作流。 保留物流行业，官网Nomos优化与Talon执行分工清楚。operational superintelligence是宣传，不归基础模型；写回和例外升级未运行核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31048", + "companyId": "YC31048", + "title": "FullSeam专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/fullseam", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为企业处理应付、应收及对账等会计工作。 移企业通用财务；前TaxProper每年十亿客户税款及被收购经历不归FullSeam收入或退出。自动处理和系统外任务比例未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31057", + "companyId": "YC31057", + "title": "Valgo专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/valgo", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为保险公司模拟自动驾驶及机器人任务的损失风险。 保留保险专业分析，不据foundational layer归基础模型。模拟损失不是实际索赔或保险收入，前公司50亿并购及FAA认证旧项目不归Valgo资质。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31064", + "companyId": "YC31064", + "title": "Origin专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/origin-bio", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "生产并许可患者来源肿瘤数据，用于药企分析及AI模型研究。 按当前数据供给移C02，兼医药科研客户；旧疗法研发定位分期。自营实验室、患者许可和模型效果未独立核，官网药品营收表不是Origin收入。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31077", + "companyId": "YC31077", + "title": "Panta专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/panta", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "由经纪人员及AI内部流程为企业配置复杂保险。 保留保险行业，不把AI-native当纯SaaS。牌照与实际合同未核，1250亿E&S保费为行业规模，不能乘假设份额估平台ARR。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31083", + "companyId": "YC31083", + "title": "Kita专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/kita", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为新兴市场贷款机构整理申请、核验财务材料并提供风险信号。 保留金融信贷应用；偿还反馈学习与更好决策是自述，未核实际效果或公平性。贷款金额、客户回款和旧雇主用户不作供应商收入。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31086", + "companyId": "YC31086", + "title": "Prescience, Inc.专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/prescience-inc", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为雇主组织健康福利、保险方案及运营服务。 保留医疗保险服务；仅省钱时收费为发布自述，具体合同未核。官网87.5万节省、零免赔及员工报价示例不当收入、普遍价格或独立医疗效果，payer/provider愿景分期。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31090", + "companyId": "YC31090", + "title": "Docura Health专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/docura-health", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为工伤评估和医法团队整理医疗记录、时间线及报告。 保留医法行业；合规摘要和更快和解为主张，未核法律/医疗资质。同行40%案件收入及医生增收不归Docura收入，软件和专业服务范围待核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31113", + "companyId": "YC31113", + "title": "CellType专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/celltype", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "以生物模型和计算平台辅助药物筛选、安全及临床转化。 保留药物研发应用，AI-agent drug company与现平台分期。Cell2Sentence论文及DeepMind合作是底层架构线索，未核公司当前成果或临床疗效；三验证命中不等获批药物。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31127", + "companyId": "YC31127", + "title": "Tepali专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/tepali", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为医疗美容及健康诊所提供病历、前台、支付和营销管理。 保留诊所全流程，预约获客为模块而非全部业务。前PJT300亿并购及Rilla经历不归Tepali收入或交易规模，医疗合规和实测效果未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31129", + "companyId": "YC31129", + "title": "Verdex专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/verdex", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "以卫星影像及天气资料辅助保险资产核验和理赔。 保留保险专业工作；11%美国农田为覆盖自述，不当付费客户或收入。监管上月更新是历史发布用语，本轮未核原文，不沿访问日解释成现行许可或即时赔付已实现。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31132", + "companyId": "YC31132", + "title": "MouseCat专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/mousecat", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为企业监测可疑活动并自动调查欺诈及合规风险。 移跨行业企业风控，未仅服务银行。Fortune500与实时模型是自述，不把降低损失当平台收入或已证控制有效，人工决策边界未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31146", + "companyId": "YC31146", + "title": "Moritz专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/moritz", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "由律师配合AI为企业交付合同及其他复杂法律事项。 保留法律服务，律师审核是必要交付。经手30亿交易不是律师费或Moritz收入；旧750客户引语、现250至2500报价和实际收款分开，900万融资排除。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31153", + "companyId": "YC31153", + "title": "Perfectly专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/perfectly", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为创业公司承接人才搜索、外联、筛选及招聘协调。 保留招聘服务，OS是包装不代表只卖软件。旧发布仅填补职位收费，官网现强调代理交付，具体合同待核；20倍效率和候选保留率未独立测试。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31156", + "companyId": "YC31156", + "title": "Ventura专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/ventura", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为工业分销及制造销售团队处理报价、订单并衔接ERP。 移客户收入运营；前Develop Health700万ARR和5人团队不归Ventura，前20亿分销客户也非本公司收入或资产。学习SOP能力与当前付费未独立核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-CAT-YC31163", + "companyId": "YC31163", + "title": "Opalite Health专业交付及业务口径复核", + "url": "https://www.ycombinator.com/companies/opalite-health", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "为医疗机构提供临床沟通中的实时语言翻译辅助。 保留医疗专业语言服务；最安全最准及百万节省均为主张，不当独立测试或合规保证。医院原口译预算不是Opalite收入，适用临床情境与人工替代率未核。", + "limitation": "仅主营及相关发布节选，行业成本、客户AUM/交易/节省、保费、融资和旧雇主业绩不当本公司收入；临床、法律、监管与技术主张未独立核。" + }, + { + "id": "INDUSTRY4-ORIGIN-HOME", + "companyId": "YC31064", + "title": "Origin数据引擎及旧业务范围", + "url": "https://origin.bio/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网描述患者组织数据、实验室与模型研究用途；结合YC当前数据许可，按科研/模型数据交付分类。", + "limitation": "未核样本来源权利、实验室或临床预测效果，官网列其他药品2025营收只是背景，非Origin收入。" + }, + { + "id": "INDUSTRY4-CELLTYPE-HOME", + "companyId": "YC31113", + "title": "CellType计算研发及论文边界", + "url": "https://www.celltype.com/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网现为药企计算筛选、安全和转化平台，列底层Cell2Sentence及合作论文入口。", + "limitation": "本轮未读论文全文或运行模型，合作架构不直接等当前公司产品已获独立测试；验证命中、临床效果和合同均待核。" + }, + { + "id": "INDUSTRY4-PERFECTLY-HOME", + "companyId": "YC31153", + "title": "Perfectly招聘代理交付", + "url": "https://www.perfectly.so/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网明确AI-native recruiting agency，提供定制接入、搜索、外联和持续优化。", + "limitation": "代理/人才交付不同于纯SaaS；效率、采用标识和无限记忆为自述，未核人员、合同及实际成功费。" + }, + { + "id": "INDUSTRY4-MORITZ-HOME", + "companyId": "YC31146", + "title": "Moritz按事项收费及律师审核", + "url": "https://www.moritzlegal.com/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网明确律师审核文件，按文档/事项预先固定报价，列250至2500、商业合同从750起及批量价格。", + "limitation": "报价和客户引语不等实收收入；律师实际工时、法域资质、平台/律所主体及收款范围待核，融资不计营收。" + }, + { + "id": "INDUSTRY4-HALADIR-HOME", + "companyId": "YC31030", + "title": "Haladir规划与执行模块", + "url": "https://www.haladir.com/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网Nomos以实时物流约束做优化，Talon负责沟通、单据及系统动作并将例外交由团队。", + "limitation": "未核求解性能、系统写回及独立任务完成率，不据superintelligence称呼认定出售基础模型。" + }, + { + "id": "INDUSTRY4-EXONIC-HOME", + "companyId": "YC30970", + "title": "Exonic官网信息缺项", + "url": "https://www.exonic.ai/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网仅可读AI for adaptive medicine标题，未取得更具体产品正文。", + "limitation": "不从标题推模型细节、实验或临床阶段；AI实际作用、付费、主体和授权继续未知。" + }, + { + "id": "INDUSTRY4-VECTOR-HOME", + "companyId": "YC31000", + "title": "Vector法律服务与平台主体", + "url": "https://www.vectorlegal.com/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网称法律由Vector Legal PC交付，VectorOS由Vector Systems PBC构建；多数按小时，也有成果或月顾问费。", + "limitation": "主体分开不等可合并收入，执照、合同及法律财务边界未独立核；AI输出需律师审核，折扣宣传不当毛利。" + }, + { + "id": "INDUSTRY4-PRESCIENCE-HOME", + "companyId": "YC31086", + "title": "Prescience健康计划与客户节省", + "url": "https://www.getprescience.com/", + "publishedAt": null, + "accessedAt": "2026-10-31", + "kind": "公司公开资料复核", + "summary": "官网服务雇主健康福利，展示87.5万客户节省及多种说明性保费/福利方案。", + "limitation": "案例节省不是公司收入；报价比较注明示例，不能把零免赔、药物福利或20%节省推为所有客户条件，承保/服务主体与合同未核。" } ], "reviews": [ @@ -59800,6 +60326,76 @@ "INDUSTRY3-PACELINE-HOME" ], "handling": "PARES现YC服务与官网软件口径并列，Prism新旧招聘报价分期，Casey实际经纪与旧基础设施发布分开。患者减免、客户报价/项目、旧基金及旧雇主收购值均排除公司收入；没有新增可比MRR，政府法律/资质及模型效果均未独立验。" + }, + { + "id": "INDUSTRY4-R-25", + "type": "行业第四批主体及专业服务收入复核", + "company": "原C07第四批25家公司", + "scope": "companies", + "companyIds": [ + "YC30962", + "YC30970", + "YC30977", + "YC30993", + "YC31000", + "YC31002", + "YC31005", + "YC31020", + "YC31025", + "YC31030", + "YC31048", + "YC31057", + "YC31064", + "YC31077", + "YC31083", + "YC31086", + "YC31090", + "YC31113", + "YC31127", + "YC31129", + "YC31132", + "YC31146", + "YC31153", + "YC31156", + "YC31163" + ], + "summary": "25项主营及相关发布已读，补8项官网资料；20项留C07，5项按交付迁移。Origin现数据供给、Vector服务/平台主体、Moritz事项费及Perfectly招聘代理分别记边界。", + "evidenceIds": [ + "INDUSTRY4-CAT-YC30962", + "INDUSTRY4-CAT-YC30970", + "INDUSTRY4-CAT-YC30977", + "INDUSTRY4-CAT-YC30993", + "INDUSTRY4-CAT-YC31000", + "INDUSTRY4-CAT-YC31002", + "INDUSTRY4-CAT-YC31005", + "INDUSTRY4-CAT-YC31020", + "INDUSTRY4-CAT-YC31025", + "INDUSTRY4-CAT-YC31030", + "INDUSTRY4-CAT-YC31048", + "INDUSTRY4-CAT-YC31057", + "INDUSTRY4-CAT-YC31064", + "INDUSTRY4-CAT-YC31077", + "INDUSTRY4-CAT-YC31083", + "INDUSTRY4-CAT-YC31086", + "INDUSTRY4-CAT-YC31090", + "INDUSTRY4-CAT-YC31113", + "INDUSTRY4-CAT-YC31127", + "INDUSTRY4-CAT-YC31129", + "INDUSTRY4-CAT-YC31132", + "INDUSTRY4-CAT-YC31146", + "INDUSTRY4-CAT-YC31153", + "INDUSTRY4-CAT-YC31156", + "INDUSTRY4-CAT-YC31163", + "INDUSTRY4-ORIGIN-HOME", + "INDUSTRY4-CELLTYPE-HOME", + "INDUSTRY4-PERFECTLY-HOME", + "INDUSTRY4-MORITZ-HOME", + "INDUSTRY4-HALADIR-HOME", + "INDUSTRY4-EXONIC-HOME", + "INDUSTRY4-VECTOR-HOME", + "INDUSTRY4-PRESCIENCE-HOME" + ], + "handling": "客户基金AUM、律师经手交易、客户节省和旧雇主税款/并购/ARR均排除营收。无新增可比MRR；模型论文关联、医学疗效、保险牌照、监管旧表述和软件/服务比例不作独立验证。" } ], "coverage": { diff --git a/content/research/ai-companies.sources.json b/content/research/ai-companies.sources.json index 7a47822..bc45b82 100644 --- a/content/research/ai-companies.sources.json +++ b/content/research/ai-companies.sources.json @@ -1,5 +1,5 @@ { - "version": "2026-10-31-industry-3", + "version": "2026-10-31-industry-4", "scopeConfirmedAt": "2026-10-30", "acceptance": "以确认的公开来源清单为边界，逐条核对并标明缺项。", "provenance": "S01—S12恢复自已提交用户的《AI公司研究_来源与分类模板》来源清单；S13—S16单列后续已使用的补充证据渠道，不将使用次数当作全量覆盖。", @@ -15,7 +15,7 @@ ], "initialAccess": "官网目录可访问", "boundary": "已读取八个2025—2026批次镜像候选池1428条，再核YC官方页面；不声称覆盖全部YC历年或未公开公司。", - "nextCheck": "原新增目录33条深化并保留来源；本快照基础项461条主营人工复核。原C07累计70项已读主营与相关发布：45保留、25按交付迁移，尚余114项规则初分。保险/地产经纪、招聘和样本物流与软件分开，PARES双模式待合同核，Prism月费/成功费与旧启动费分期；患者减免、客户报价/项目、基金、索赔和旧雇主成果不作公司收入。本快照C05仍89项规则初分，继续纳入后续结果；其他非人工资料、主体、财务、技术及非YC来源覆盖仍缺。", + "nextCheck": "原新增目录33条深化并保留来源；本快照基础项486条主营人工复核。原C07累计95项已读主营与相关发布：65保留、30按交付迁移，尚余89项规则初分。Origin数据许可、Vector法律/平台主体、Moritz事项费、Perfectly招聘服务及医疗保险双线分别待合同核；客户AUM/交易/节省和旧雇主税款/并购/ARR排除营收。本快照C05仍89项规则初分，后续结果另纳入。主体、付费、财务、技术以及全部公开来源覆盖缺项继续保留。", "limitation": "批次不等于成立年；不代表全部公司" }, { diff --git a/content/research/ai-income-analysis.json b/content/research/ai-income-analysis.json index 8dd5118..eb45e72 100644 --- a/content/research/ai-income-analysis.json +++ b/content/research/ai-income-analysis.json @@ -1,5 +1,5 @@ { - "sourceVersion": "2026-10-31-industry-3", + "sourceVersion": "2026-10-31-industry-4", "asOf": "2026-10-31", "metric": "platform-mrr-usd", "sampleUnit": "product-or-business",